Breaking News

B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site

Increased availability of IV solutions to address shortages stemming from ongoing COVID-19 crisis.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

B. Braun Medical Inc., a provider of infusion therapy and pain management solutions, has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical manufacturing plant in Daytona Beach, FL. The site will produce 0.9% sodium chloride for injection available in B. Braun’s Excel Plus IV Bags in 1,000 mL and 500 mL sizes. The Excel Plus IV bags are not made with PVC, DEHP or natural rubber latex. The new Daytona Beach facility is part of B. Braun&#82...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters